Is Sermorelin Legal in South Carolina? How to Access It Legally
See the public record for Sermorelin
At a glance
- FDA status today / Not approved; Geref discontinued 2008, approvals withdrawn 2009 [1]
- What is available now / Compounded preparations, not FDA-reviewed [2]
- FDA safety-risk list / Sermorelin is not on it [3]
- Outsourcing-facility nominations / Category 1, under evaluation [5]
- HHS peptide enforcement draft, October 2026 / Sermorelin not among the six named peptides [4]
- Sport / WADA prohibits it at all times [6]
- Approved uses, historically / Pediatric growth hormone deficiency and a pituitary diagnostic test [1]
What is sermorelin's federal status today?
Sermorelin was FDA-approved as Geref under two applications: NDA 019863, a 0.05 mg/ampule product indicated for evaluating the pituitary's ability to secrete growth hormone, approved December 28, 1990; and NDA 020443, 0.5 mg and 1 mg vials indicated for treating idiopathic growth hormone deficiency in children with growth failure, approved September 26, 1997 [1].
The manufacturer discontinued both products in 2008 and asked FDA to withdraw the applications, and FDA withdrew approval effective June 18, 2009 [1]. In March 2013 FDA determined that Geref was not withdrawn from sale for reasons of safety or effectiveness, and Drugs@FDA lists both as discontinued with that determination noted [1][8]. Those two are the only sermorelin applications in Drugs@FDA [1][8].
Where sermorelin sits on FDA's compounding lists
- It is not listed on FDA's page of bulk substances that may raise significant safety risks when compounded, content dated 04/22/2026 [3].
- On the outsourcing-facility nomination list, updated March 21, 2025, sermorelin acetate is in category 1, under evaluation, marked as a component of FDA-approved drugs [5].
- It does not appear in any category on FDA's separate list for state-licensed pharmacies and physicians, updated May 14, 2026 [7].
- It is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [4].
What was Geref approved for, and what was it not?
The approved uses were narrow: treating idiopathic growth hormone deficiency in children with growth failure, and a diagnostic test of pituitary growth hormone reserve [1]. Geref was not approved for adults, anti-aging, weight loss or athletic performance [1]. Sermorelin is a 29-amino-acid analogue of growth hormone-releasing hormone and is not growth hormone itself [9].
South Carolina
The federal records above do not say which South Carolina prescribers may prescribe sermorelin or which pharmacies may prepare it. State rules would be a separate question from the federal status described here.
Questions worth asking
Is sermorelin allowed in sport?
No. WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, prohibited at all times in and out of competition [6], and the 2027 List names it as well [10].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is sermorelin legal in South Carolina?
Why is sermorelin no longer FDA-approved?
Was Geref pulled for safety reasons?
Does sermorelin appear on FDA's compounding safety-risk list?
Can athletes use prescribed sermorelin?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
How can I get prescribed sermorelin?
No prescribing process is described. Federal records do not say which South Carolina prescribers may prescribe sermorelin, and state rules would be a separate question from the federal status. No sermorelin product is FDA-approved today.
Where can I safely obtain sermorelin peptide?
No safe source is named. Sermorelin products in the United States today are compounded drugs, which FDA does not review for safety, effectiveness or quality before they are marketed. Federal records also do not say which South Carolina pharmacies may prepare it.
Where can I buy sermorelin peptide online?
Online sellers are not covered. Sermorelin products in the United States today are compounded preparations that FDA has not reviewed. Whether a South Carolina pharmacy may prepare it is a state question that the federal records do not settle.
References
Show all 10 referencesHide references
- Federal Register. Determination That Geref (sermorelin acetate) Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register, 2013. Determination that Geref (sermorelin acetate) was not withdrawn for safety or effectiveness
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Official web page.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- World Anti-Doping Agency.